- Home
- BPMC vs SFBS Comparison
BPMC vs SFBS Comparison
Compare BPMC & SFBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- SFBS
- Stock Information
- Founded
- BPMC 2008
- SFBS 2005
- Country
- BPMC United States
- SFBS United States
- Employees
- BPMC N/A
- SFBS N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- SFBS Major Banks
- Sector
- BPMC Health Care
- SFBS Finance
- Exchange
- BPMC Nasdaq
- SFBS Nasdaq
- Market Cap
- BPMC 5.9B
- SFBS 5.2B
- IPO Year
- BPMC 2015
- SFBS 2014
- Fundamental
- Price
- BPMC $90.14
- SFBS $85.85
- Analyst Decision
- BPMC Buy
- SFBS Hold
- Analyst Count
- BPMC 20
- SFBS 2
- Target Price
- BPMC $120.79
- SFBS $71.50
- AVG Volume (30 Days)
- BPMC 667.8K
- SFBS 266.2K
- Earning Date
- BPMC 02-13-2025
- SFBS 01-27-2025
- Dividend Yield
- BPMC N/A
- SFBS 1.40%
- EPS Growth
- BPMC N/A
- SFBS N/A
- EPS
- BPMC N/A
- SFBS 3.74
- Revenue
- BPMC $434,415,000.00
- SFBS $426,982,000.00
- Revenue This Year
- BPMC $108.09
- SFBS N/A
- Revenue Next Year
- BPMC $39.34
- SFBS $18.05
- P/E Ratio
- BPMC N/A
- SFBS $22.96
- Revenue Growth
- BPMC 100.93
- SFBS 0.15
- 52 Week Low
- BPMC $72.24
- SFBS $58.05
- 52 Week High
- BPMC $121.90
- SFBS $101.37
- Technical
- Relative Strength Index (RSI)
- BPMC 42.11
- SFBS 34.48
- Support Level
- BPMC $86.02
- SFBS $84.98
- Resistance Level
- BPMC $98.41
- SFBS $94.41
- Average True Range (ATR)
- BPMC 3.28
- SFBS 2.76
- MACD
- BPMC -0.76
- SFBS -1.44
- Stochastic Oscillator
- BPMC 33.04
- SFBS 7.13
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company. It originates commercial, consumer, and other loans and accepts deposits, provides electronic banking services, such as online and mobile banking, including remote deposit capture, delivers treasury and cash management services, and provides banking services to other financial institutions. The company offers services which include telephone banking, direct deposit, Internet banking, mobile banking, boxes, and automatic account transfers.